drugset / Trial / NCT06655311

A Study of Enlicitide Chloride (MK-0616) in Healthy Participants and Participants Taking Statins (MK-0616-012)

NCT06655311

Phase 1 Completed 56 enrolled Merck Sharp & Dohme LLC
RandomizedParallel-groupDouble-blindTreatment

Summary

The goal of this study is to learn what happens to different doses of enlicitide chloride over time in the body of healthy participants and participants taking statins, a group of medicines used to reduce the levels of high cholesterol in the bloodstream. The researchers want to learn about the safety of enlicitide chloride when administered at high doses.

Timeline

Start
2022-09-30
Primary completion
2024-01-02
Completion
2024-01-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Enlicitide Unknown Oral

Indications